🇺🇸 FDA

Intelligence · Patent portfolio

BioMarin Pharmaceutical Australia Patents

Full USPTO pharma patent portfolio for BioMarin Pharmaceutical Australia — grant dates, expiration, and drug cross-links.

Patents
175
Expiring ≤24m
2

Quick answer

BioMarin Pharmaceutical Australia has 175 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 4

  1. US 9567572

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9540395

    Histone deacetylase inhibitors

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9528109

    Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA

    Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9512143

    Histone deacetylase inhibitors

    Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9504762

    Adeno-associated virus factor VIII vectors

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9499818

    Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9469683

    Lysosomal targeting peptides and uses thereof

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9433624

    Methods and compositions for the treatment of metabolic disorders

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9376480

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9375453

    Methods for producing bioeffective krill oil compositions

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9320765

    Bioeffective krill oil compositions

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9295683

    Omega-3 phospholipid supplements for improved brain maturity

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9265734

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9243245

    Means and methods for counteracting muscle disorders

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9220735

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9216178

    Dry blend formulation of tetrahydrobiopterin

    Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9200264

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9119864

    Bioeffective krill oil compositions

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9089566

    Delivery of therapeutic compounds to the brain and other tissues

    Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9078905

    Bioeffective krill oil compositions

    Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9072752

    Bioeffective krill oil compositions

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9044473

    Delivery of therapeutic compounds to the brain and other tissues

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9034388

    Bioeffective krill oil compositions

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9029530

    Detection of oligosaccharides

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9028877

    Bioeffective krill oil compositions

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8999987

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8957066

    Histone deacetylase inhibitors

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8940513

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8859498

    Targeted therapeutic proteins

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8785168

    Formulations for lysosomal enzymes

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8765945

    Processes of synthesizing dihydropyridophthalazinone derivatives

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8765437

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8735392

    Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8697138

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8598121

    Variants of C-type natriuretic peptide

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8563691

    Lysosomal targeting peptides and uses thereof

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8541403

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8492337

    Targeted therapeutic proteins

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8492338

    Targeted therapeutic proteins

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8420650

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8420368

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8377884

    Variants of C-type natriuretic peptides

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8372812

    Phospholipid and protein tablets

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8349894

    Compositions comprising an o/w emulsion containing conjugated linoleic acid

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8324210

    Pterin analogs

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8207225

    Conjugated linoleic acid compositions

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8207114

    Targeted therapeutic proteins

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does BioMarin Pharmaceutical Australia have?

175 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BioMarin Pharmaceutical Australia patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.